Company Filing History:
Years Active: 2018
Title: Innovations by Gregory Alan Watkins
Introduction
Gregory Alan Watkins is an accomplished inventor based in Oakland, California. He has made significant contributions to the field of drug delivery systems, particularly in the development of a device for the sustained release of antipsychotic medications. His innovative approach addresses critical needs in medication management for patients requiring long-term treatment.
Latest Patents
Watkins holds a patent for a device and method for the sustained release of antipsychotic medications. This drug delivery device features a non-erodible, non-porous housing member that defines a reservoir. The reservoir is filled with a dry formulation of a selected salt of a neuroleptic agent. The housing member includes one or more porous partitions, which are designed to retain insoluble powder particles while allowing the active agent to diffuse once the device is hydrated. This innovative device releases a therapeutic dose of the drug at a constant rate over a period of approximately 2 to 6 months.
Career Highlights
Watkins is associated with Delpor, Inc., a company focused on advancing drug delivery technologies. His work at Delpor has been instrumental in developing solutions that enhance patient compliance and improve therapeutic outcomes. His expertise in the field has positioned him as a key player in the pharmaceutical industry.
Conclusion
Gregory Alan Watkins exemplifies innovation in drug delivery systems, with his patented device offering a promising solution for the sustained release of antipsychotic medications. His contributions continue to impact the healthcare sector positively.